JP MORGAN/PUT/BECTON DICKINSON AND CO./230/0.1/17.01.25 Share Price

Warrant

DE000JL1KNJ6

Market Closed - Börse Stuttgart 08:20:00 14/06/2024 BST
1.96 EUR +8.29% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./230/0.1/17.01.25
Current month-12.11%
1 month+1.03%
Date Price Change
14/06/24 1.96 +8.29%
13/06/24 1.81 -2.16%
12/06/24 1.85 +12.12%
11/06/24 1.65 0.00%
10/06/24 1.65 +3.12%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 08:20 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNJ
ISINDE000JL1KNJ6
Date issued 05/04/2023
Strike 230 $
Maturity 17/01/2025 (215 Days)
Parity 10 : 1
Emission price 1.75
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.27
Lowest since issue 1.6
Spread 0.15
Spread %7.32%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW